Table 2. Expression of T-bet and GATA3 in 109 PTCL tumor samples by immunohistochemistry.
T-bet | GATA-3 | |||||||
---|---|---|---|---|---|---|---|---|
No. | – | + | ++ | No. | – | + | ++ | |
PTCL-NOS | 60 | 34 (56.7) | 21 (35.0) | 5 (8.3) | 60 | 35 (58.3) | 21 (35.0) | 4 (6.7) |
NKT | 18 | 10 (55.6) | 4 (22.2) | 4 (22.2) | 18 | 8 (44.4) | 9 (50.0) | 1 (5.6) |
AITL | 11 | 8 (72.7) | 3 (27.3) | 0 (0.0) | 11 | 3 (27.3) | 6 (54.5) | 2 (18.2) |
ALK+ ALCL | 4 | 2 (50.0) | 2 (50.0) | 0 (0.0) | 4 | 0 (0.0) | 2 (50.0) | 2 (50.0) |
ALK- ALCL | 4 | 2 (50.0) | 1 (25.0) | 1 (25.0) | 4 | 3 (75.0) | 1 (25.0) | 0 (0.0) |
Others | 12 | 7 (58.3) | 4 (33.3) | 1 (8.3) | 12 | 10 (83.3) | 1 (8.3) | 1 (8.3) |
Total | 109 | 63 (57.8) | 35 (32.1) | 11 (10.1) | 109 | 59 (54.1) | 40 (36.7) | 10 (9.2) |